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ABSTRACT (200 words) 
DNA methylation is essential in mammalian cells, and its patterns are faithfully 
reproduced at each round of DNA replication. The protein UHRF1 is crucial for this 
process: it binds recently replicated regions and causes the recruitment of the DNA 
methyltransferase DNMT1, ensuring maintenance methylation. The Tandem Tudor 
Domain (TTD) of UHRF1 is critical for its function; it binds H3K9me2/3, but also 
unmethylated linker regions within UHRF1 itself, causing auto-inhibition. Recently, it 
was reported that a methylated histone-like region of DNA Ligase 1 (LIG1K126me3) 
outcompetes H3K9me2/3 for TTD binding, permitting UHRF1 recruitment to chromatin. 
Here we report the crystal structure of the UHRF1 TTD bound to a methylated LIG1 
peptide. The structure is validated by functional cellular assays and reveals the key 
residues for interaction and the mechanism for high affinity binding of LIG1. 
Furthermore, single molecule analysis demonstrates that binding of LIG1 changes the 
overall structure of UHRF1 to a flexible conformation, suggesting that UHRF1 
auto-inhibition is relieved. This is the first reported structure of UHRF1 bound to a 
methylated non-histone protein, and our results provide structural insight into how 
UHRF1 performs its key function in epigenetic maintenance. 
3		
 
INTRODUCTION 
DNA methylation and histone modifications are major epigenetic marks that 
regulate diverse cellular events by modulating the structure and function of chromatin (1, 
2). In mammals, DNA methylation occurs mostly at the 5th position of cytosine in CpG 
dinucleotides and plays key roles in development, X-chromosome inactivation, genome 
imprinting and carcinogenesis (3–6). In proliferating cells, the pattern of DNA 
methylation has to be re-established after each cycle of DNA replication, and two 
proteins are known to be key in this process, as their absence causes a similar phenotype 
of progressive DNA demethylation (7–11). The first protein involved is the maintenance 
DNA methyltransferase, DNMT1, and the other is the protein UHRF1 (Ubiquitin-like, 
containing PHD and RING finger domains, 1).  
UHRF1 contains five annotated domains: Ubiquitin-Like (UBL); Tandem 
Tudor Domain (TTD); Plant Homeo Domain (PHD); SET and RING Associated (SRA), 
and Really Interesting New Gene (RING), and their associated linkers. The SRA is 
essential for function and specifically recognizes hemi-methylated DNA, which is 
generated after DNA replication (12–14). Subsequently the RING domain, which has E3 
ubiquitin ligase activity, ubiquitylates K14, K18 and/or K23 on histone H3 (hereafter 
H3), which allows DNMT1 recruitment onto recently replicated sites, (15–17). The 
PHD and TTD work cooperatively to recognize the heterochromatin mark H3K9me2/3: 
the PHD recognizes the N-terminus of the histone, while the TTD accommodates the 
methylated H3K9me2/3 residue in an aromatic cage (18–21). In addition, the TTD also 
interacts with unmethylated lysine and arginine-rich linkers within UHRF1 itself: the 
"spacer" which follows the SRA domain (spacerUHRF1) and the "linker 2" between TTD 
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and PHD finger (L2UHRF1) (18, 21–23). These intramolecular interactions lead to a 
"closed" overall structure and the auto-inhibition of DNA binding and E3 activities 
(22–24). 
We recently showed that the TTD interacts with a histone-like sequence within 
a replication protein, DNA Ligase 1 (LIG1) (25). Molecularly, LIG1 contains an 
intrinsically disordered region (IDR) at its N-terminus (residues 1-200), within which 
residues 118-130 are similar to the H3 N-terminal tail (residues 1-12), and LIG1K126 is 
in a sequence environment similar to H3K9. Furthermore, LIG1K126 is methylated by 
the lysine methyltransferases G9a and GLP (EHMT1 and EHMT2) in vitro and in cells. 
We found that a LIG1K126me3 peptide largely outcompetes H3K9me2/3 peptides for 
binding to the UHRF1 TTD. We also reported that the aromatic cage of the TTD was 
necessary for binding, yet a number of molecular questions remain open as to how 
UHRF1 interacts with this methylated non-histone protein. What are the similarities 
between H3K9me2/3 and LIG1K126me3 binding? What are the differences, and how 
do they contribute to the higher affinity binding to LIG1? What is the effect of LIG1 
binding to the overall UHRF1 architecture and function?  
To address these questions, we have solved the crystal structure of the UHRF1 
TTD in complex with a methylated LIG1 peptide. The structure, complemented by 
mutagenesis and functional assays reveals key residues for the interaction, sheds light on 
the mechanism for high affinity binding of LIG1 to TTD, and indicates that the binding 
event causes a large-scale molecular reorganization within UHRF1. Our data provide 
the first insight into UHRF1 binding to a methylated non-histone protein, and contribute 
to understanding its key role in epigenetic maintenance.  
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MATERIAL AND METHODS 
 
Peptide preparation 
The human LIG1 peptides, residues 118-130 
(NH2-118IPKRRTARKQLPK130-COOH) harboring K126me3, R121A-K126me3, 
R125A-K126me3 or T123ph-K126me3, and histone H3 K9me3 
(NH2-1ARTKQTAR-K(me3)-STGGKAPRKQ19-COOH) were purchased from Toray 
Research Center (Tokyo, Japan).  
 
Crystallography of TTD and its complex with LIG1-K126me3 peptide 
The TTD of human UHRF1 (residues 123-285) was expressed as a fusion 
protein with glutathione S-transferase (GST) and small ubiquitin like modifier-1 
(SUMO-1) at its N-terminus. Cell culture and purification were performed according to 
our previous report (18). Cocrystallization of this wild-type TTD with the 
LIG1-K126me3 peptide was unsuccessful, so we used instead a mutant version of the 
TTD, deleting residues 167-175. The protocols of cell culture and purification of the 
deletion mutant are the same as for wild-type TTD.  
Crystals of apo-TTD were obtained by using a reservoir solution containing 0.1 
M Bis-Tris (pH 6.5), 200 mM ammonium acetate and 25% (w/v) polyethylene glycol 
(PEG) 3,350 at 4°C. The crystals were cryoprotected by 20% (v/v) ethylene glycol. 
Diffraction data were collected at a wavelength of 1.5418 Å on a RIGAKU R-AXIS 
IV++ equipped with MicroMax 007 (RIGAKU). Data were processed with program 
XDS package (26) and Aimless (27) at 1.7 Å resolution. The structure of apo-TTD was 
solved by molecular replacement method using the coordinates of the human UHRF1 
TTD (PDB; 3DB3) as a search model. Molecular replacement and model refinement 
were performed using PHASER (28) and PHENIX (29). After several cycles of 
refinement, the model converged well at 1.7 Å resolution with a crystallographic 
R-factor of 17.9 % and free R-factor of 24.2%.  
 The TTD: LIG1-K126me3 complex was prepared by adding a 1.5-molar excess 
of the LIG1-K126me3 peptide to the protein before concentration using an Amicon 
concentrator with a 10,000 Da cutoff (Millipore). The crystal was obtained using a 30 
mg/ml concentration of the complex at 20°C and the hanging drop vapor diffusion 
method with a reservoir solution containing 100 mM Tris-HCl (pH 7.0), 200 mM 
tri-potassium phosphate and 20% (w/v) PEG3350. The crystal was directly frozen in 
liquid nitrogen using a cryoprotectant containing 20% (v/v) ethylene glycol. The X-ray 
diffraction data were collected at a wavelength of 0.98000 Å on a Pilatus3 6M detector 
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in beam line BL-17A at Photon Factory (Tsukuba, Japan) and scaled at 2.65 Å 
resolution with the program XDS package and Aimless. After molecular replacement by 
PHASER and several cycle of model refinement by PHENIX, 2|Fo| - |Fc| difference 
Fourier map corresponding to LIG1-K126me3 were unambiguously observed. The final 
model converged at 2.65 Å resolution with a crystallographic R-factor of 23.1% and a 
free R-factor of 28.8%.  
The crystallographic data and refinement statistics are given in Table 1. The 
figures were generated using Pymol (http://www.pymol.org). 
 
ITC measurements 
Cell culture and purification of UHRF1 PHD were performed according to our 
previous report (18). Mutants of TTD (residues 123-285) were generated by the 
Quickchange mutagenesis method (Agilent Technologies). Purified UHRF1 TTD or its 
mutants were buffer-exchanged using Superdex 200 Increase 10/300 GL (GE 
HealthcareScience) equilibrated with the ITC buffer (10 mM HEPES-NaOH (pH 7.5), 
150 mM NaCl, 0.25 mM tris(2-carboxyethyl)phosphine Hydrochloride (TCEP)). 
Lyophilized LIG1 peptides (residues 118-130) and H3K9me3 peptide (residues 1-19) 
were dissolved in the same buffer. A MicroCal LLC calorimeter, VP-ITC (MicroCal), 
was used for the ITC measurements. The TTD solution in the calorimetric cell was 
titrated with the peptide solution at 293 K. The data were analyzed with the software 
ORIGIN (MicroCal) using a one-site model. 
 
Fluorescent three-hybrid assay (F3H) 
 The starting plasmids for F3H were: full-length human UHRF1 cloned in 
pEGFP-C2 (plasmid PAD1543) (25) and full-length human LIG1, cloned in pmRFP-C2 
(plasmid PAD1766) (25). The various mutations were introduced by Gibson Assembly 
Cloning. The F3H assay were performed as previously described (30), using BHK cells. 
Each experiment was carried out at least twice independently, with 100 cells scored in 
blind in each repetition. 
 
SAXS 
 Protein preparation of the TTD-PHD, residues 123-366, is described in a 
previous paper (18). The TTD-PHD in complex with LIG1-K126me3 or H3K9me3 was 
prepared by adding a 2.0-molar excess of the peptide to the protein. Before SAXS 
measurements, the proteins were loaded to Superdex 200 Increase 10/300GL to 
eliminate aggregates. SAXS measurements were performed at 4 °C with a 
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MicroMax007HF X-ray generator (Rigaku) equipped with a PILATUS100K detector 
(DECTRIS) at a distance of 561 mm from the sample. Circular averaging of the 
scattering intensities was carried out to obtain one-dimensional scattering data I(q) as a 
function of q (q = 4πsinθ/λ, where 2θ is the scattering angle and λ is the X-ray 
wavelength 1.5418 Å). To correct for interparticle interference, I(q) data were collected 
at three different protein concentrations (1.0, 1.5, and 2.0 mg/ml in 20 mM Tris-HCl (pH 
7.5), 150 mM NaCl, 5 mM DTT, 5 mM β-mercaptoethanol, 2  mM TCEP and 10 µM 
ZnOAc). The total exposure times were 3 hours for each sample. Because the intensity 
profile did not indicate a concentration effect, the correction for interparticle 
interference was not applied. To estimate the molecular weight of samples, I(q) data 
were collected for chicken egg white lysozyme (4.9 mg/ml in 20 mM Tris-HCl (pH 7.5), 
150 mM NaCl). The data were processed by using the software applications embedded 
in the ATSAS package (31). The radius of gyration Rg and forward scattering intensity 
I(0) were estimated from the Guinier plot of I(q) in the smaller angle region of qRg < 1.3. 
The distance distribution function P(r) was calculated in the program GNOM (32), 
where the experimental I(q) data were used in a q-range from 0.031 to 0.300 Å−1. The 
maximum particle dimension Dmax was estimated from the P(r) function as the distance 
r for which P(r) = 0. The molecular weight of the sample was estimated by comparing 
I(0)/c (where c is the protein concentration) of the sample to that of lysozyme. 
 
HS-AFM observations 
 To produce the full-length protein with N-terminal 6×histidine (His6) tag, the 
full-length human UHRF1 cDNA was sub-cloned into pGEX6P-1 (GE 
HealthcareScience). Bacterial culture and purification of the protein was performed 
according to our previous report (16).  
 HS-AFM imaging was performed in solution at room temperature using a 
laboratory-built HS-AFM setup (33, 34) as described previously (35). In brief, a glass 
sample stage (diameter, 2 mm; height, 2 mm) with a thin mica disc (1 mm in diameter 
and ~0.05 mm thick) glued to the top by epoxy was attached onto the top of a Z-scanner 
by a drop of nail polish. A freshly cleaved mica surface was prepared by removing the 
top layers of mica using Scotch tape. Then, a drop (2 µl) of diluted protein sample (ca. 3 
nM) in dilution buffer (20 mM Tris-HCl (pH 7.5), 500 mM NaCl and 10% glycerol) was 
placed on the mica surface. After incubation for 3 min at room temperature, the mica 
surface was rinsed with 20 µl of the observation buffer (20 mM Tris-HCl (pH 7.5), 150 
mM NaCl) to remove floating samples. The sample stage was then immersed in a liquid 
cell containing ~60 µl of the observation buffer. AFM Imaging was carried out in the 
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tapping mode, using small cantilevers (BLAC10DS-A2, Olympus, Tokyo, Japan); 
resonant frequency, ~0.5 MHz in water; quality factor, ~2 in water; spring constant, 
~0.1 N/m. The cantilever’s free oscillation amplitude A0 and set-point amplitude As were 
set at 1−2 nm and ~0.9 × A0, respectively. The imaging rate, scan size and the pixel size 
for each AFM image are 150 ms/frame, 60 × 60 nm2 and 80 × 80 pixels, respectively. 
 
Analysis of AFM images 
 For analysis, AFM images were pretreated with a low-pass filter to remove 
spike noise and with a flatten filter to make the overall xy-plane flat, using a laboratory 
built software as described before (35). This software is available at 
https://elifesciences.org/content/4/e04806/article-data-fig-data-supplementary-material. 
The heights of molecules were measured semi-automatically using the following steps. 
First, the most probable highest point near the highest point of the molecule was 
selected manually. Second, the actual highest point was automatically determined by 
searching a 10 × 10 pixel area (typically 7.5 × 7.5 nm2) around the selected point. 
 2D correlation coefficients were calculated between the HS-AFM images of the 
first frame and each of the frames within the Region of Interest (ROI) (i.e., the first 
frame is the reference). The sizes of the ROIs were about 25×25 nm2. The 2D 
correlation coefficient was calculated frame-by-frame for each ROI. The 2D correlation 
coefficient r is defined as,  
 
in which Hmn and Rmn are the heights at the pixel point (m, n) in the ROI to be analyzed 
and the reference ROI of the reference frame, respectively.  and  are the mean 
values of the height matrices H and R, respectively. 
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RESULTS 
 
The TTD in complex with LIG1-K126me3 peptide adopts a canonical structure 
Cocrystallization of the wild-type human TTD (residues 123-285) with the 
LIG1K126me3 peptide was not successful. After optimization trials, we used for 
co-crystallization a variant TTD (vTTD from here on), with deletion of a flexible loop 
(residues 167-175). This deletion mutant has essentially the same binding properties for 
LIG1-K126me3 as the wild type TTD (data not shown). The LIG1 peptide contained 
residues 118-130 of the human protein, with the key lysine K126 trimethylated 
(K126me3).  
We determined the crystal structure of vTTD with LIG1-K126me3 peptide at 
2.65 Å resolution (Table 1); in the crystal, an asymmetric unit contained two 
TTD:LIG1-K126me3 complexes. The structures of the two TTD in the unit were 
identical (root mean square deviation (RMSD) of Cα atoms 1.401 Å over the 125 Cα 
atoms) (Supplementary Figure S1A). The structure of LIG1-K126me3 peptides in the 
asymmetric unit was also identical (RMSD of Cα atoms 0.456 Å) (Supplementary 
Figure S1B). The twelve successive residues from Ile118 to Pro129 showed clear 
electron density in a |Fo| - |Fc| omit map (Figure 1A, B), and are described hereafter. 
Finally, for comparison purposes, we also determined the structure of unliganded TTD; 
the resolution obtained was 1.70 Å (Table 1).  
The overall TTD structure was virtually identical with or without the 
LIG1-K126me3 peptide (RMSD of Cα atoms 0.8~1.6 Å) (Supplementary Figure S1A), 
implying that binding of the LIG1-K126me3 did not lead to the structural rearrangement 
of the TTD. As in previously published structures (23, 36), the 1st and 2nd tudor 
domains comprised a five-stranded β-barrel fold, and the two domains were separated 
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by a groove (TTD groove from here on, Supplementary Figure S1A). The 
LIG1-K126me3 peptide interacted in an extended conformation with TTD groove and, 
within the peptide, residues Arg121 to Lys126me3 contacted TTD residues (Figure 1A 
and E). 
 
Two regions of the LIG1-K126me3 peptide establish dense contacts with the TTD  
The structure showed that two clusters of dense contacts between TTD and 
LIG1 peptide participated to the stable complex formation. First, the aromatic cage 
comprising Phe152, Tyr188 and Tyr191 of UHRF1 interacted with tri-methyl moiety of 
K126me3 in LIG1 (Figures 1C and E). Second, the side chain of LIG1Arg121 was 
inserted into the hole of the TTD groove; there, the guanidino group and aliphatic 
portion of Arg121 were recognized by multiple hydrogen bonds and hydrophobic 
interactions with side chains of UHRF1Asp142 and Met224, Trp238 and Phe278, 
respectively (Figures 1D and E). Of these positions, Asp142, Met224 and Trp238 are 
almost invariant within UHRF1 homologs found in animal species, whereas Phe278 is 
conserved but at a lower level (Supplementary Figure S2. NB: we should swap figures 
S2 and S3, as we use the alignment first in the text). In addition to these dense contacts, 
the side chains of Arg122 and Arg125 of LIG1 were recognized by the side chain of 
Glu276 and the main chain of Asp190 of TTD, respectively (Figures 1C-E). Glu193 of 
TTD also supported the binding to LIG1Arg125 by long-range electrostatic interaction 
(~3.7 Å) (Figure 1C). The side chain of LIG1Thr123 formed additional hydrogen bonds 
with the side chain of UHRF1Trp238 (Figure 1D). Finally, the main chains of Arg121, 
Arg122, Ala124 and K126me3 in LIG1 were also involved in the interaction with TTD 
(Figure 1E).  
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Our published work (25), as well as data presented here, suggest that the TTD 
of UHRF1 has much higher affinity for methylated LIG1 than for its other reported 
interactors: H3K9me3, spacerUHRF1 and L2UHRF1 (18, 22, 23, 36). To understand the 
basis for this preference, we compared the peptide sequences and structural data for all 
these interactions; as a reference point in the alignments we assign position "N" to 
LIG1Arg121 (Figure 2A). The sequences of the interacting peptides show similarities, 
such as basic residues preferred at positions N-1, N, and N+1, Ser or Thr at N+2, and 
small aliphatic residues at N+3. The structural data, showed large differences in the 
extent to which the residues interact with the TTD (Figure 2A-E). LIG1 had the highest 
number of interactions, as the side chains of residues N, N+1, N+2, N+4 and N+5 
interacted with the TTD. In contrast, H3K9me3 interaction with the TTD did not engage 
N+1 nor N+4. When bound to the TTD, the spacerUHRF1 and L2UHRF1 failed to engage 
either N+1, N+4 or N+5 residues, although the N-1 position of spacerUHRF1 formed 
hydrophilic interaction with the TTD that were not seen with the other peptides. 
Collectively, it is likely that the larger number of hydrophilic and hydrophobic 
interactions formed between LIG1-K126me3 and TTD underlie the higher binding 
affinity. 
 
Mutational analysis validates the structural data and uncovers a phospho-switch 
regulation 
To validate our structural data and quantify the contribution of individual 
residues to the interaction, we performed isothermal titration calorimetry (ITC) 
experiments using WT or mutated versions of the TTD and LIG1 peptide (Figure 3A; 
Supplementary Figure S2). The values obtained with WT partners were consistent with 
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our previous reports (18, 25): the TTD bound LIG1-K126me3 with a KD = 9.11 ± 3.80 
nM and LIG1-K126me0 with a KD = 250 ± 38 nM (Figure 3A). In contrast to the 
binding of H3K9me3, no detectable interaction was observed between LIG1-K126me3 
and UHRF1 PHD finger, indicating that binding to LIG1 is limited to the TTD groove 
(Supplementary Figure S2).  
We tested several mutations of the TTD (Figure 3A; Supplementary Figure S3). 
The mutation with the most deleterious effect was D142A, which obliterated any 
detectable binding. The second most deleterious change was inactivation of the aromatic 
cage, using the double mutation Y188A/Y191A which resulted in detectable but vastly 
reduced affinity for LIG1K126me3 (KD = 5.38 ± 0.49 µM). Mutation W238A also had a 
large effect, reducing the affinity a hundred-fold (KD = 1.06 ± 0.04 µM). Finally, 
mutations E193A and E276A had smaller but measurable effects on the 
UHRF1/LIG1-K126me3 interaction. All of these critical residues are shared between 
UHRF1 and UHRF2, so we tested the possibility that UHRF2 might also bind LIG1; 
ITC experiments showed that it was indeed the case (Supplementary Figure S3). 
Next, we introduced mutations in the LIG1-K126me3 peptide. The R121A 
change had a severe effect, reducing binding at least 6000-fold (Figure 3A, KD > 55 
µM); in contrast the R125A mutation only led to a slight binding reduction (KD =21.4 ± 
1.1 nM). Finally, it has been observed that phosphorylation of the N+2 position inhibits 
the interaction of TTD with H3K9me3 (20), L2UHRF1 (18) and spacerUHRF1 (22, 23), so 
we tested whether this might also occur in the case of LIG1. We synthetized a peptide in 
which LIG1K126 was trimethylated, and LIG1T123 phosphorylated; this peptide 
interacted extremely poorly with the TTD (KD > 104 µM, Figure 3A), establishing that 
phosphorylation at N+2 is indeed inhibitory to the interaction. 
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We also examined the interaction by an independent technique, the fluorescent 
three-hybrid assay (F3H) (30). In this approach, proteins bearing fluorescent tags are 
co-expressed in an engineered mammalian cell line, which is designed so that the 
GFP-tagged protein will be recruited to a nuclear focus. The percentage of cells in 
which the RFP-tagged protein forms a focus colocalizing with the GFP focus is then 
recorded, and provides a direct estimate of the interaction propensity in cells (Schematic 
in Figure 3B). We carried out this assay with full-length UHRF1 fused to GFP, and 
full-length LIG1 fused to DsRed, using WT proteins or introducing the mutations 
studied by ITC. The F3H results agreed very well with ITC: mutation D142A in UHRF1 
had a severe effect, W238A was less marked, and E193A and/or E276A had smaller 
effects (Figure 3C; Supplementary Figure S4A). Within LIG1, the R121A mutation 
totally abrogated interaction, and so did the phosphomimetic T123D mutation. A 
striking difference with the ITC results is that the LIG1R125A mutation led to total loss 
of interaction in the F3H assay (Figure 3D; Supplementary Figure S4B). A likely 
explanation is that the LIG1R125A mutant protein fails to be methylated on K126, as 
G9a requires an RK motif in its target to catalyze lysine methylation (37). 
Altogether, the data from ITC and F3H are fully consistent with the structure 
we obtained. Moreover, they reveal that the ionic interaction between Asp142 of TTD 
and Arg121 of LIG1 plays a foremost role in the binding, followed by the hydrophobic 
interaction between LIG1K126me3 and the TTD hydrophobic cage. Lastly, we have 
shown that the interaction can be negatively regulated by phosphorylation of LIG1T123.  
 
Binding to LIG1 changes the arrangement of the TTD-PHD module and the 
overall UHRF1 structure 
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In the TTD-PHD functional module, L2UHRF1 interacts with the TTD groove 
and positions the PHD relative to the TTD (18, 22, 23). H3K9me3 binding does not 
change the overall arrangement of the TTD-PHD, as judged by crystal structure and 
small angle X-ray scattering (SAXS) (18, 38). In contrast, mutating key residues of 
L2UHRF1 (R295 and R296) or employing a compound that binds the groove, 
4-benzylpiperidine-1-carboximidamide (BPC), does make the TTD-PHD less compact 
(18, 38). We asked if this would also be observed upon LIG1 binding and for this we 
used SAXS (Figures 4A; Supplementary Figures S5A-C). 
We used the distance distribution function P(r) to calculate the radius of 
qyration (Rg) and Dmax value (Figure 4A; Supplementary Figure S5B and C). The 
numbers obtained for apo-TTD-PHD were similar to those previously reported (18, 38), 
and they were not affected by the addition of H3K9me3 (Figure 4A), again agreeing 
with our previous report. In contrast, the addition of LIG1K126me3 caused a marked 
increase in the radius of gyration, implying a rearrangement of the TTD-PHD module to 
a more open form. The structural change is similar to TTD-PHD R295A/R296A 
mutation, which lost the interaction between L2UHRF1 and the TTD groove, thus 
suggesting that LIG1-K126me3 binding extruded the L2UHRF1 from the groove. 
To reveal the effect of LIG1-K126me3 binding to the overall UHRF1 structure, we 
switched to a different approach: single-molecule analysis of the full length UHRF1 by 
High-Speed Atomic Force Microscopy (HS-AFM), a powerful technique for real-space 
and real-time observations of macromolecules (39). Imaging of the N-terminal 
histidine-tagged UHRF1 on Ni2+ coated mica demonstrated that apo-UHRF1 appeared 
as a compact molecule with a diameter of 3.89 ± 0.28 nm estimated from height 
analyses (Figure 4B and C; Supplementary Movie 1 and Figure S6). In contrast, binding 
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of LIG1-K126me3 significantly decreased the compactness of the particle: its height 
was diminished to 2.44 ± 0.25 nm (Figure 4B and C; Supplementary Movie 2 and 
Figure S7), indicating that the structure of UHRF1 was changed to a more open form. 
HS-AFM also yielded information about the dynamics of the molecules: the correlation 
coefficients for sequential HS-AFM images of apo-UHRF1 were distributed around 
0.867 ~ 0.969, indicating a rather static structure, whereas those of UHRF1:LIG1 
complexes were lower (0.404 ~ 0.915), indicative of increased conformational 
flexibility (Figure 4D; Supplementary Figure S6 and S7). 
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DISCUSSION 
 
 We report the first structure of the UHRF1 TTD bound to a methylated 
non-histone protein, LIG1. This interaction is physiologically important, as it permits 
the recruitment of UHRF1 to replicating DNA, and the maintenance of DNA 
methylation, an essential epigenetic mark in mammals (25). Our structural data are 
validated by independent biochemical and cellular approaches, and they shed light on 3 
important questions: what distinguishes LIG1 interaction from interaction with other 
TTD binders, what may regulate this interaction, and how the interaction allosterically 
regulates UHRF1.  
 
Structure of the UHRF1 TTD complexed with LIG1 reveals commonalities and 
differences with other interactors 
A first conclusion from our data is that the TTD engages LIG1 in a manner 
similar to its other targets: the LIG1 peptide was extended in the TTD groove as 
previously reported for H3, the L2UHRF1 and spacerUHRF1. Another commonality between 
the various interactions is that they all involve a basic residue (Arg or Lys, R121 in the 
case of LIG1) in the binder, which penetrates deep in the groove and forms an 
electrostatic interaction with Asp142 of UHRF1, a residue that is highly conserved 
through evolution (Supplementary Figure S3). Finally, another similarity with previous 
structures is that the methylated lysine (LIG1K126me3) is accommodated by the 
aromatic cage formed of UHRF1 Phe152, Tyr188, and Tyr 191, as is the case for 
H3K9me3 (18, 21, 36). 
These similarities imply that the binding of the TTD to its various interactors 
must be mutually exclusive, raising the question of how LIG1 can outcompete the other 
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binders. Indeed L2UHRF1 and spacerUHRF1 form with the TTD intramolecular interactions, 
which should have a much higher probability of contact, especially at lower UHRF1 
concentrations. As for H3K9me3 molecules, they form intermolecular interactions with 
the TTD, but they outnumber LIG1 by a factor of ~100 (25). To be able to engage the 
TTD, it is expected that LIG1 should have an affinity significantly higher than the other 
binders, and this is in fact what we observe (25). In the crystal structure, Arg122 and 
Arg125 of LIG1 formed interactions not seen for H3K9me3, spacerUHRF1 or L2UHRF1. 
Based on these and other observations, we suggest that the high avidity of LIG1 for the 
TTD results from a combination of several hydrophilic and hydrophobic interactions 
that are not formed by the other binders.  
Another piece of insight gained from the structure is that the UHRF1 residues 
that interact with LIG1 are conserved in UHRF2, and we experimentally validated that 
the UHRF2 TTD interacts with LIG1. Therefore LIG1 binding is probably a shared 
activity, and the fact that UHRF1 and UHRF2 are not exchangeable (PMID:21598301; 
22064703) must involve one or several other functions.  
 
Possible modes of regulation 
The interaction between LIG1 and UHRF1 is highly affine in vitro, and easily 
detectable in cells. Nevertheless, it seems likely that the complex undergoes dissociation 
at some points in time and space, so that LIG1 can fulfill its catalytic activity —the 
ligation of Okazaki fragments— while UHRF1 remains on replicated DNA to ensure H3 
ubiquitylation, DNMT1 recruitment, and possibly allosteric DNMT1 activation (15–17, 
40, 41). How may the interaction between LIG1 and UHRF1 be dissociated?  
A first and obvious possibility is the demethylation of LIG1K126me3, which 
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reduces affinity ~30-fold in vitro. Of note, ~80% of LIG1 molecules carry K126 
methylation in cells (25), suggesting that if K126 demethylation occurs, it is a transient 
event. Future work may reveal if such an event exists, and which enzyme is involved.  
Our data reveal at least 3 additional possibilities. The first is methylation of 
LIG1R121, which is predicted to disrupt the key electrostatic interactions with 
UHRF1D142. The second is methylation of LIG1R125, which is predicted to prevent 
G9a from methylating LIG1K126, and should therefore phenocopy our LIG1R125A 
mutation. FEN1, the flap endonuclease acting just before LIG1 during replication, is 
regulated by arginine methylation (42), and it could be of interest in the future to ask 
whether LIG1 is also targeted on R121 and R125 by arginine methyltransferases. Finally, 
the third is phosphorylation of LIG1Thr123; we experimentally showed that it decreases 
affinity for the TTD ~10000-fold. Interestingly, this mechanism could be conserved 
between interactions, as phosphorylation of the equivalent residues (H3Thr6, Ser298 in 
L2UHRF1, and Ser651 in spacerUHRF1) has a similar effect (18, 23, 43). Thr123 of LIG1 is 
within a consensus sequence for Protein Kinase Cβ (PKCβ) (44), and this kinase 
phosphorylates H3Thr6 (45), so it could also possibly regulate the LIG1/UHRF1 
interaction.  
 
LIG1 as an allosteric effector of UHRF1: functional consequences 
Several reports have unambiguously established that full-length UHRF1 
undergoes intramolecular interactions, causing it to present a compact physical aspect, 
causing the inhibition of its molecular activities (22–24). Using HS-AFM, we confirm 
that UHRF1 is compact, and further observe that its conformation becomes more open 
and more dynamic once it interacts with LIG1. Therefore, LIG1 can be added to 
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phosphatidylinositol 5-phosphate, hemimethylated DNA, and H3K9me3 as an allosteric 
regulator of UHRF1.  
In spite of this similarity, LIG1 also presents a key difference with H3K9me3 
with respect to its effect on the TTD and PHD domains. Indeed it has been shown by 
several investigators that these two domains form a functional module, in which the 
PHD is precisely positioned relative to the TTD thanks to L2UHRF1, which binds the TTD 
groove. The addition of H3K9me3 does not disrupt this architecture: instead H3K9me3 
adopts a constrained conformation so that its N terminus binds the PHD, and its C 
terminus binds the TTD (18, 20). In clear contrast, our SAXS experiments show that 
LIG1 does modify the TTD-PHD module, towards a more open conformation; 
presumably this happens by displacing L2UHRF1 from the groove. Our ITC experiments 
also show that the PHD does not detectably bind the LIG1 peptide, and this is consistent 
with expectations as LIG1 does not present the free N-terminal 1ARTK4 motif that is 
critical for interaction with the PHD (18, 19, 46, 47). Therefore, our data suggest that, 
when UHRF1 is bound to LIG1, the PHD domain is released and free to engage in other 
intra- or inter-molecular interactions. These complex dynamics may be necessary to 
order, in space and time, the different functions that UHRF1 has to fulfill: recruitment to 
recently replicated DNA, methylation of histones, and activation of DNMT1.  
Taken together, our results contribute to a better understanding of the critical 
epigenetic regulator UHRF1, and will guide future experiments to further study its 
functions.  
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The crystal structures of the apo-TTD and its complex with LIG1-K126me3 peptide 
have been deposited in the Protein Data Bank under accession code YYYY and XXXX, 
respectively. 
 
SUPPLEMENTARY DATA 
 
 
ACKNOWLEDGEMENTS 
We would like to thank the beamline staff at the Photon Factory for X-ray data 
collection. 
 
FUNDING 
This study was supported by a PRESTO from JST (K.A.). PAD was supported by 
Association pour la Recherche contre le Cancer (ARC2014), and by Agence Nationale 
de la Recherche (ANR-15-CE12-0012-01 and ANR-11-LABX-0071 under 
ANR-11-IDEX-0005-01).  
 
 
Conflict of interest statement: None declared. 
21		
FIGURE LEGENDS 
 
Figure 1. Structure of the UHRF1 TTD in complex with a LIG1-K126me3 peptide. 
(A) Overall structure of TTD:LIG1-K126me3 complex. 1st and 2nd tudor domains are 
shown as yellow-green and pale-green surface models, respectively. LIG1 is depicted as 
magenta stick model. (B) The LIG1 and |Fo| - |Fc| omit map contoured at 2 σ are colored 
magenta and blue, respectively. (C), Recognition of R125-K126me3 and (D), 
R121-A124 of LIG1 by the TTD. Color schemes are the same as in Figure 1A. Water 
molecules are represented as black balls. (E), Schematic diagram of LIG1-K126me3 
recognition by the TTD. The LIG1 backbone and side chains are shown in black and 
TTD residues in green. Dotted lines and black arcs with spokes indicate hydrogen bonds 
and hydrophobic interactions respectively.  
 
Figure 2. Structural comparison of TTD binding partners.  
(A), Sequence alignment of LIG1, H3, spacerUHRF1 and L2UHRF1. Arg121 of LIG1 is 
defined as position ‘N’. Residues from N to N+5 are colored pink, green yellow, cyan, 
orange and magenta, respectively. The residues underlined have a side chain that 
interacts with the TTD. Structure around the TTD groove in complex with (B) 
LIG1-K126me3, (C) H3K9me3 (PDB ID: 2L3R), (D) spacerUHRF1 (PDB ID: 5IAY) and 
(E) L2 UHRF1 (PDB ID: 3ASK). Each peptide is shown as stick model and the color 
schemes are same in Figure 2A. Red and blue on the surface of TTD indicate 
hydrophilic and hydrophobic interaction residues, respectively.  
 
Figure 3. Mutation analysis confirms the structural data and uncovers a negative 
regulation by phosphorylation.  
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(A), Determination of binding affinities by ITC. TTD with the indicated mutations and 
LIG1 with the indicated the PTMs were subjected to ITC experiments and the derived 
KD values are expressed as the fold-decrease from that of interaction between wt TTD 
and LIG1-K126me3. KD values with standard deviations determined by ITC are also 
depicted under the bar in the graph. (B), Principle of the F3H assay. (C), Mutations in 
the UHRF1 TTD affect interaction with LIG1. (D), Mutations in LIG1 affect interaction 
with the UHRF1 TTD.  
 
Figure 4. Decreased compactness and increased dynamics of UHRF1 upon LIG1 
binding.  
(A), SAXS experiments on the TTD-PHD module. P(r) functions are shown for 1.5 
mg/ml of apo-TTD-PHD (blue) and its complex with H3K9me3 (green) and 
LIG1-K126me3 peptides (red). Rg and Dmax values are also shown. (B), Successive 
HS-AFM images showing representative molecular shape of apo-UHRF1 (upper) and its 
complex with LIG1-K126me3 (lower). Frame rate, 150 ms/frame; scan area, 60 × 60 
nm2 with 80 × 80 pixels; Z-scale, 4.5 nm in apo-UHRF1 and 3.5 nm in the complex. (C) 
Height distributions: blue bars for the apo-UHRF1; pink bars for the 
UHRF1:LIG1-K126me3 complex. Blue and red lines indicate single-Gaussian fitting for 
apo-UHRF1 and UHRF1:LIG1-K126me3 complex, respectively. (D) Time courses of 
correlation coefficients between the sequential HS-AFM images of apo-UHRF1 (blue) 
and its complex with LIG1-K126me3 (red). 
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Plasmid cotransfected with DsRed-LIG1: GFP-
UHRF1 with following mutations
WT D142A E193A E276A W238A
90% 1% ~80% ~50% ~35%
% cells with green/red colocalization
Plasmid cotransfected with GFP-UHRF1:  
DsRed-LIG1 with following mutations
WT R121E T123D R125A R125E
90% 0% 0% 0% 1%
% cells with green/red colocalization
0 50 100
F
re
q
u
e
n
c
y
 (
%
)
Height (nm)
apo-UHRF1
UHRF1：LIG1-K126me3
A
B
C D
11.40 s 23.25 s 27.90 s 28.80 s
20 nm
0 nm
3.5 nm
0 nm
4.5 nm
39.90 s
20 nm
29.85 s19.80 s9.90 s
0 1 2 3 4 5
0
5
10
15
20
25
UHRF1:LIG1-
K126me3
apo-UHRF1
r (Å)
P
(r
) 
/ 
I(
0
) 
(a
.u
.)
 
Figure 4
C
o
rr
e
la
ti
o
n
 c
o
e
ff
ic
ie
n
ts
Times (s)
apo-UHRF1
UHRF1：LIG1-K126me3
0
0.2
0.4
0.6
0.8
1
0 10 20 30 40
Rg (Å) Dmax (Å)
apo-UHRF1 23.7 84
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Green: TTD in the complex, chain A
Cyan: TTD in the complex, chain B
Orange: apo-TTD
Magenta: LIG1 in complex, chain C
White: LIG1 in complex, chain D
RMSD of Cα atoms: 0.456 Å
A B
Supplementary Figure S1 | Structural comparison of TTD and LIG1.
(A) Structures of apo-TTD and its complex with LIG1-K126me3 in the asymmetric
unit are shown as orange, green and cyan cartoon model, respectively. The
orientation is same as Figure 1A. (B) Stick-model structures of two LIG1 peptides
in the asymmetric unit are colored magenta and white, respectively.
1st tudor domain 2nd tudor domain
N
N
N
C
C
C
RMSD of Cα atoms
apo-TTD: chain A 1.626 Å
apo-TTD: chain B 0.812 Å
chain A: chain B 1.401 Å
TTD wt : 
LIG1-K126me3
KD = 9.11 ± 3.80 nM
TTD D142A :
LIG1-K126me3
KD = not detectable
TTD Y188A/Y191A :
LIG1-K126me3
KD = 5.38 ± 0.49 µM
TTD W238A :
LIG1-K126me3
KD = 1.06 ± 0.04 µM
TTD wt : 
H3K9me31-19
KD = 612 ± 97 nM
TTD wt :
LIG1-K126me0
KD = 250 ± 35 nM
TTD wt : LIG1-
R121A/K126me3
KD =  >55 µM
TTD wt : LIG1-
T123ph/K126me3
KD = >104 µM
TTD wt : LIG1-
R125A/K126me3
KD = 21.4 ± 1.1 nM
PHD wt : 
LIG1-K126me3
KD = not detectable
TTD E193A : 
LIG1-K126me3
KD = 23.0 ± 8.2 nM
TTD E276A : 
LIG1-K126me3
KD = 49.7 ± 11.1 nM
Supplementary Figure S2 | ITC thermograms (upper) and plots of corrected
heat values (lower) for the binding of the LIG1 peptides to the TTD, PHD or
UHRF2 TTD.
The first data point of each measurement was omitted from the plots in the lower
panels and parameter fittings.
UHRF2 TTD wt : 
LIG1-K126me3
KD = < 0.43 nM
Supplementary Figure S3 | Multiple sequence alignment of the TTD region in
UHRF1 proteins and human UHRF2. Numbering is based on the sequence of
human UHRF1. Letters in red indicates the residues involved in recognition of
LIG1. Fully and partially conserved amino acids are highlighted in light-orange and
blue, respectively.
120 130 140
human - - - A A A E - - T D S R P A D E D M W D E T E L G L Y K V N E Y V D A R
mouse - - - G A A E - - A D D K - - - - T V W E D T D L G L Y K V N E Y V D V R
rat - - - G T A D - - G D D K - - - - T V W E D T D L G L Y K V N E Y V D V R
Bovin - - - A A N E - - P E G K - A D E D E C D E T E L G L Y K V G E Y V D A R
Xenopus - - - M D V D - - - - - G Q S I S I I G E N V G T S L Y K K N D L V D A R
zebrafish - - - S D V Q S A G A S G Q T D T A D L I D P G F G F Y K I N E F V D A R
UHRF2 N Q P - - - - - - - - - S T S A R A R L I D P G F G I Y K V N E L V D A R
150 160
human D T N M G A W F E A Q V V R V T R K A P - - - - - - - - - - - - - - - - -
mouse D N I F G A W F E A Q V V Q V Q K R A L - - - - - - - - - - - - - - - - -
rat D N I F G A W F E A Q V V Q V Q K K A L - - - - - - - - - - - - - - - - -
Bovin D T N M G A W F E A K V I R V T R K A P - - - - - - - - - - - - - - - - -
Xenopus D L N M G A W F E A Q I V N V S K K V G - - - - - - - - - - - - - - - - -
zebrafish D L N M G A W F E A Q I V K V T K T P A - - - - - - - - - - - - - - - - -
UHRF2 D V G L G A W F E A H I H S V T R A S D G Q S R G K T P L K N G S S C K R
170 180
human - - - - - - - - - - - - - - - - S R D E P C S S T S R P A L E E D V I Y H
mouse - - - - - - - - - - - - - - - - S E D E P C S S S A V K T S E D D I M Y H
rat - - - - - - - - - - - - - - - - S E E E P C S S S A I M A P E D D I M Y H
Bovin - - - - - - - - - - - - - - - - A H D Q P S S S S S K - - P E D D I I Y H
Xenopus - - - - - - - - - - - - - - - - P Y G T L P E V S D T S V T S D A I I Y H
zebrafish - - - - - - - - - - - - - - - - E D G - - - - - - - - - - G A E S I V Y H
UHRF2 T N G N I K H K S K E N T N K L D S V P S T S N S D C V A A D E D V I Y H
190 200 210 220
human V K Y D D Y P E N G V V Q M N S R D V R A R A R T I I K W Q D L E V G Q V
mouse V K Y D D Y P E H G V D I V K A K N V R A R A R T V I P W E N L E V G Q V
rat I K Y D D Y P E H G V D I V K A K N V R A R A R T V I P W E D L E V G Q V
Bovin V T Y D D Y P E N G V V Q M T S Q N V R A R A R H T I K W E D L Q V G Q V
Xenopus V K Y E D Y P E N G V V Q L T C K D V R L R A R T T L P W H E I K V G Q V
zebrafish V K Y E D Y P E N G V V Q L R G K D V R P R A R T V Y Q W H Q L E P G M I
UHRF2 I Q Y D E Y P E S G T L E M N V K D L R P R A R T I L K W N E L N V G D V
230 240 250
human V M L N Y N P D N P K E R G F W Y D A E I S - R K R E T R T A R E L Y A N
mouse V M A N Y N V D Y P R K R G F W Y D V E I C - R K R Q T R T A R E L Y G N
rat V M A N Y N V D Y P R K R G F W Y D V E I C - R K R Q T R T A R E L Y G N
Bovin V M V N Y N P D L P K D R G F W Y D A E I L - R K R E T R T A R E L H A N
Xenopus V M V N Y N P D E P K E R G Y W Y D A E I L - R K H E S K K I K E I Y A K
zebrafish V M V N Y N P D D P K E R G Y W Y D A E I Q - R K R E T R T Q R E V F G K
UHRF2 V M V N Y N V E S P G Q R G F W F D A E I T T L K T I S R T K K E L R V K
260 270 280 290
human V V L G D D S - - L N D C R I I F V D E V F K I E R P G E G S P M V D N P
mouse I R L L N D S Q - L N N C R I M F V D E V L M I E L P K E R R P L I A S P
rat V M L L N D S Q - L N N C R I I F V D E V L K I E L P N E R S P L I G S P
Bovin V R I G G D S - - L N D C R I V F V D E V F K I E R P G E G N P M V E N P
Xenopus V L L G D A G D S L N D C R I R F V N E I Y K I E E P G S T Y L N T E S P
zebrafish I L L G D A G D S L N D C R I M F V T E I Y K I E E P G S A E G P G A S S
UHRF2 I F L G G S E G T L N D C K I I S V D E I F K I E R P G A H P L S F A D G
Supplementary Figure S4 | The F3H assay confirms the interaction between
UHRF1 and LIG1 mutants. (A) Illustrative F3H images with UHRF1 point mutants.
n = 100 cells scored in at least two independent experiments in this and all
subsequent F3H data. (B) Illustrative F3H images with LIG1 point mutants.
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Supplementary Figure S5 | SAXS measurements of experimental I(q) profiles
and Guinier plots of TTD-PHD with or without LIG1-K126me3 or H3K9me3
peptides.
(A) I(q) profiles of apo-TTD-PHD (left) and its complex with H3K9me3 (middle) and
LIG1-K126me3 (right), obtained from SAXS data. The SAXS data of scattering
curves were collected at three different protein concentrations, 2.0 (red), 1.5
(orange) and 1.0 mg/ml (green). (B) Guinier plots apo-TTD-PHD (left) and its
complex with H3K9me3 (middle) and LIG1-K126me3 (right). (C) SAXS parameters
for UHRF1 TTD-PHD and its complex with LIG1-K126me3 or H3K9me3. *a based
on Guinier analysis. *b calculated from P(r) function. *c MW: molecular weight
estimated from SAXS data of Lysozyme
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Supplementary Figure S6 | HS-AFM observations of apo-UHRF1
(A) AFM images and height analysis of seven representative molecules. Z-scale is
4.5 nm. (B) Time courses of 2D correlation coefficients between the sequential HS-
AFM images of seven representative molecules.
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Supplementary Figure S7 | HS-AFM observations of UHRF1:LIG1-K126me3
(A) AFM images and height analysis of seven representative molecules. Z-scale is
3.5 nm.(B) Time courses of 2D correlation coefficients between the sequential HS-
AFM images of seven representative molecules.
